Inhibition of human carcinoma and neuroblastoma cell proliferation by anti-c-myc siRNA
- PMID: 16584292
- DOI: 10.1089/oli.2006.16.15
Inhibition of human carcinoma and neuroblastoma cell proliferation by anti-c-myc siRNA
Abstract
Suppression of c-myc proto-oncogene expression by small interfering RNA (siRNA) in human epidermoid carcinoma KB-3-1 and neuroblastoma SK-N-MC cell lines was investigated. The siRNA duplex targeted to the exon 3 of c-myc mRNA (siRNA-I) was prepared by in vitro transcription using T7 RNA polymerase and short double-stranded DNA (dsDNA) templates. siRNA-I was shown to efficiently decrease c-myc mRNA expression in both tumor cell lines and to arrest their proliferation. Incubation of KB-3-1 cells with 150 nM siRNA-I results in a 92% decrease in the c-myc mRNA level and an 83% decrease in the protein level. In SK-N-MC cells, 150 nM siRNA-I causes a 60% decrease in the c-myc mRNA level and a 55% decrease in the protein level. The reduction of the c-myc mRNA level correlates with the inhibition of cell proliferation; 150 nM siRNA-I causes a 2.5-fold reduction in the SK-N-MC proliferation rate and a 15-fold decrease in the proliferation rate and complete arrest of cell division in KB-3-1 cells. siRNA-I has little effect on proliferation of the IMR-32 cells that overexpress the N-myc but not the c-myc gene, demonstrating that siRNA-I antiproliferation activity is mediated by specific block of c-myc expression.
Similar articles
-
[Silencing of c-myc gene expression by enzymatically and chemically synthesized siRNAs].Mol Biol (Mosk). 2006 Nov-Dec;40(6):1037-46. Mol Biol (Mosk). 2006. PMID: 17209432 Russian.
-
Silencing of c-myc expression in tumor cells by siRNA.Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(6-7):867-72. doi: 10.1081/NCN-200026033. Nucleosides Nucleotides Nucleic Acids. 2004. PMID: 15560074
-
Arrest of cancer cell proliferation by dsRNAs.Ann N Y Acad Sci. 2006 Dec;1091:425-36. doi: 10.1196/annals.1378.085. Ann N Y Acad Sci. 2006. PMID: 17341633
-
Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.Cancer Res. 2001 Feb 1;61(3):1073-9. Cancer Res. 2001. PMID: 11221835
-
Anti-c-myc RNAi-Based Onconanotherapeutics.Biomedicines. 2020 Dec 15;8(12):612. doi: 10.3390/biomedicines8120612. Biomedicines. 2020. PMID: 33333729 Free PMC article. Review.
Cited by
-
Molecular Mechanism of the Antiproliferative Activity of Short Immunostimulating dsRNA.Front Oncol. 2019 Dec 20;9:1454. doi: 10.3389/fonc.2019.01454. eCollection 2019. Front Oncol. 2019. PMID: 31921696 Free PMC article.
-
Opaganib Downregulates N-Myc Expression and Suppresses In Vitro and In Vivo Growth of Neuroblastoma Cells.Cancers (Basel). 2024 May 5;16(9):1779. doi: 10.3390/cancers16091779. Cancers (Basel). 2024. PMID: 38730731 Free PMC article.
-
Antitumor efficacy of a sequence-specific DNA-targeted γPNA-based c-Myc inhibitor.Cell Rep Med. 2024 Jan 16;5(1):101354. doi: 10.1016/j.xcrm.2023.101354. Epub 2024 Jan 5. Cell Rep Med. 2024. PMID: 38183981 Free PMC article.
-
New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids.Acta Naturae. 2009 Jul;1(2):44-60. Acta Naturae. 2009. PMID: 22649602 Free PMC article.
-
Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy.Biomaterials. 2013 Nov;34(33):8459-68. doi: 10.1016/j.biomaterials.2013.07.050. Epub 2013 Aug 8. Biomaterials. 2013. PMID: 23932296 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical